Volex PLC exceeded revenue expectations with at least $710 million in H1 2026/27, driven by strong demand in data centres and electric vehicles, surpassing broker forecasts. Peel Hunt and Jefferies maintained 'buy' ratings, highlighting robust commercial momentum and improved profitability. Growth in data centres and EV sectors is expected to continue, with potential new upgrade cycles in 2027/28. Jefferies raised its price target and earnings forecasts, reflecting confidence in Volex's long-term outlook despite recent share price gains.
Volex's growth and broker ratings provide context for Pluang's Industrials sector data. For readers following Industrials, here is Pluang's market snapshot as of Oct 19, 2026 19:22 WIB: out of 135 priced US stocks, 89 rose and 26 fell. Notable movers include ENVX at USD 2.57 (+3.21%), AMSC at USD 26.48 (+3.16%), and FIX at USD 1,482.59 (+3.02%).
Disc Medicine's stock surged 38% following positive Phase 3 trial results for its drug bitopertin, which showed efficacy and safety in treating erythropoietic protoporphyria. BMO Capital raised its price target from $100 to $120 and maintained an Out...
Qualcomm executive Ann C. Chaplin sold 1,827 shares of the company's stock for $319,268.25 under a Rule 10b5-1 trading plan, reducing her holdings by 6.62%. Qualcomm's stock price recently traded below its 50-day and 200-day moving averages, signalin...
BOK Financial is set to announce its Q3 2026 earnings after market close on October 19, with analysts forecasting earnings per share between $2.52 and $2.54 and revenue near $571 million. The company has a strong history of surpassing earnings estima...
AIBotics has completed the acquisition of NovaCore Labs' assets from PlayJamaica Limited, gaining technology, software, drones, mapping equipment, and customer contracts. This move expands AIBotics' platform in Jamaica and the Caribbean, enhancing AI...
EyePoint's stock dropped sharply after its DURAVYU treatment did not meet the primary endpoint in a Phase 3 trial for wet age-related macular degeneration (wet AMD). Although DURAVYU showed some vision improvement and reduced the need for additional ...
